RECRUITING

Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research study is testing a new behavioral therapy called Episodic Future Thinking or EFT can help people reduce drug use and risky sexual behaviors while helping them adhere to their HIV prevention medication (PrEP). Participants will be randomly assigned to one of two groups. One group will receive standard care, which includes counseling on HIV prevention, drug use reduction, and sexual health. The other group will receive standard care plus a new program called Episodic Future Thinking (EFT), where participants will think about and plan for their future goals using a mobile app and counseling sessions. Study procedures that are not part of regular care include filling out surveys, providing blood, urine, and swab samples for testing, and using the EFT app.

Official Title

Development of a Behavioral Economic Intervention to Improve HIV-related Behaviors Among Sexual Minority Individuals

Quick Facts

Study Start:2025-03-03
Study Completion:2027-07-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06745947

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 34 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults 18 - 34 years of age
  2. * HIV negative (assessed via Rapid HIV Antibody Test)
  3. * Identify as gay, bisexual or transgender
  4. * Recent (past 3 months) methamphetamine use
  5. * Currently prescribed and taking HIV PrEP medication
  6. * Self-reported HIV PrEP nonadherence in the past three months
  7. * Urine screen test for PrEP nonadherence
  8. * Self-reported condomless anal sex or a STI in the past three months
  9. * Able to attend all study visits
  10. * Fluent in English
  1. * Currently receiving treatment for any substance use disorder,
  2. * HIV positive
  3. * Having a medical or psychiatric illness that in the opinion of the PI would interfere with study participation
  4. * Unable to provide informed consent
  5. * Unable to attend protocol directed study visits
  6. * Any plans that would preclude study completion (e.g. surgery, major medical treatments such as chemotherapy, incarceration, travel/moving out of San Antonio, Texas)

Contacts and Locations

Study Contact

Emeka Okafor, PhD, MPH
CONTACT
210-450-7377
okaforcn@uthscsa.edu

Principal Investigator

Emeka Okafor, PhD, MPH
PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center at San Antonio

Study Locations (Sites)

University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229
United States

Collaborators and Investigators

Sponsor: The University of Texas Health Science Center at San Antonio

  • Emeka Okafor, PhD, MPH, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center at San Antonio

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-03
Study Completion Date2027-07-01

Study Record Updates

Study Start Date2025-03-03
Study Completion Date2027-07-01

Terms related to this study

Keywords Provided by Researchers

  • HIV negative
  • Methamphetamine use
  • HIV PrEP medication

Additional Relevant MeSH Terms

  • HIV Prevention